§ 13F · FUND PROFILE
Pivotal bioVenture Partners Investment Advisor LLC.
AUM · $308M (13F)Positions · 13Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$32M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | PCVX | VAXCYTE INC | 1.43M | $83M | 26.9% | +4% |
| 2 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1.27M | $33M | 10.8% | −7% |
| 3 | TRVI | TREVI THERAPEUTICS INC | 1.74M | $33M | 10.6% | +12% |
| 4 | AVLN | AVALYN PHARMACEUTICALS INC | 967K | $32M | 10.3% | NEW |
| 5 | EVMN | EVOMMUNE INC | 1.93M | $26M | 8.3% | ±0% |
| 6 | MPLT | MAPLIGHT THERAPEUTICS INC | 611K | $22M | 7.1% | ±0% |
| 7 | OCS | OCULIS HOLDING AG | 1.51M | $21M | 6.8% | −10% |
| 8 | BIOA | BIOAGE LABS INC | 653K | $16M | 5.2% | ±0% |
| 9 | IMNM | IMMUNOME INC | 733K | $16M | 5.0% | ±0% |
| 10 | ZBIO | ZENAS BIOPHARMA INC | 491K | $12M | 4.0% | −17% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PIVOTAL SIGNAL
AC read
Pivotal bioVenture Partners Investment Advisor LLC is a Other fund managing $308 million in assets. The fund runs a focused portfolio of just 13 positions.
Read the full dossier →